Origin Energy Ltd hits new 52-week high – is it time to sell?

Or is Origin Energy Ltd's (ASX:ORG) turnaround just getting started?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Origin Energy Ltd (ASX: ORG) have hit a new 52-week high of $7.20 this morning. Although a far cry from the $13 seen as recently as mid-2015, today's price represents a significant recovery from lows of $4 a year ago.

Shares are up on higher oil prices, as well as news that Origin will spin off its non-core assets into a separate company. As I said at the time, the proposed spin-off company appears more interesting than debt-burdened Origin.

In fact, with Origin's share price at its highest point all year, if I was a holder I might be more inclined to sell than to buy more. The company still carries $9 billion in debt, and it'll be selling off some of its most promising prospects, including the Waitsia and BassGas fields soon.

That will reduce the debt burden, and a more focused and less indebted Origin will be in a better position to generate improvements from its APLNG plant and electricity retailing business. Also, the current higher oil prices will boost the company's cash flow and a temporary decision to cancel the dividend can't hurt.

Yet I'm thinking that much of the potential benefit of these measures is already factored into Origin's share price. Further earnings growth requires higher oil and gas prices and/or an increase in profitability as a result of lower interest expenses, the addition of a second train to APLNG, or similar. At today's prices and with a market capitalisation of $12.6 billion, Origin is valued at around 35x last year's underlying earnings.

That's too much to pay in my opinion, and the possible upside in my opinion isn't more than 20% to 30% in the next 1 to 2 years. I think it more likely that Origin shares will trade sideways over that time. I just don't see much of an opportunity in the company today.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »